LRMR icon

Larimar Therapeutics
LRMR

Overview Fund Activity

93 hedge funds and large institutions have $880M invested in Larimar Therapeutics in 2015 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 9 closing their positions.

Holders
93
Holders Change
+35
Holders Change %
+60.34%
% of All Funds
2.48%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
44
Increased
32
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FCMI
1
Foresite Capital Management II
California
$56.5M
2
DM
2
Deerfield Management
New York
$41.6M
3
JHIU
3
Janus Henderson Investors US
Colorado
$31.3M
4
Jennison Associates
4
Jennison Associates
New York
$37.8M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$21.1M

Top Sellers

1
TRV
1
Third Rock Ventures
Massachusetts
$166M
2
PA
2
Perceptive Advisors
New York
$0
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$0
4
SFM
4
Sphera Funds Management
Israel
$0
5
Principal Financial Group
5
Principal Financial Group
Iowa
$2.23M
Name Market Value Shares Shares
Change 		Shares
Change %
MLICM
101
Metropolitan Life Insurance Company (MetLife)
New York
– – -152 Closed
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
– – -3 Closed
1 2 3 4
5